Literature DB >> 10629138

Terminal deoxynucleotidyl transferase-negative acute lymphoblastic leukemia.

J Faber1, H Kantarjian, M W Roberts, M Keating, E Freireich, M Albitar.   

Abstract

OBJECTIVE: Terminal deoxynucleotidyl transferase (TdT) is a useful marker in the diagnosis of acute lymphoblastic leukemia (ALL) (French-American-British [FAB] L1 and L2) and is most useful in distinguishing ALL from mature B-lymphoid neoplasms, such as Burkitt lymphoma (FAB L3) and other lymphoid malignancies. The frequency of TdT-negative ALL is not known. Here we report 3 TdT-negative ALL cases that met the criteria for T-cell ALL.
DESIGN: We reviewed approximately 200 cases of ALL retrieved from the database at our institution. All cases were evaluated using Wright-Giemsa, myeloperoxidase, butyrate, and TdT staining; immunophenotyped using flow cytometry; and studied using Southern blot analyses for T-cell receptors and immunoglobulin gene rearrangement.
RESULTS: All ALL cases (L1 and L2) were TdT-positive, except for 3 cases that were of early T-cell lineage. None of the 3 cases demonstrated positivity for TdT in immunofluorescence staining with polyclonal antibodies or flow cytometry with monoclonal antibodies. Flow cytometric analysis confirmed a pre-T-cell immunophenotype in all 3 cases. One of the cases showed rearrangement of a T-cell antigen receptor and immunoglobulin heavy chain (J(H)). A second case showed germline configuration of T-cell receptors, but also showed rearrangement of the J(H), despite the expression of T-cell markers only.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10629138     DOI: 10.5858/2000-124-0092-TDTNAL

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  8 in total

1.  Alcohol Consumption Modulates Host Defense in Rhesus Macaques by Altering Gene Expression in Circulating Leukocytes.

Authors:  Tasha Barr; Thomas Girke; Suhas Sureshchandra; Christina Nguyen; Kathleen Grant; Ilhem Messaoudi
Journal:  J Immunol       Date:  2015-11-30       Impact factor: 5.422

2.  Terminal deoxynucleotidyl transferase (TdT)-negative T-cell lymphoblastic lymphoma with loss of the T-cell lineage-specific marker CD3 at relapse: a rare entity with an aggressive outcome.

Authors:  Masroor Hassan; Hafez Mohammad Ammar Abdullah; Abdul Wahid; Muhammad Ashraf Qamar
Journal:  BMJ Case Rep       Date:  2018-06-08

3.  Splenic rupture and mediastinal mass associated with rare TdT-negative T-LBL/T-ALL lead to sudden death of a juvenile.

Authors:  Dominic Gascho; Bettina Huber; Stephan A Bolliger; Michael J Thali; Sarah Schaerli
Journal:  Forensic Sci Med Pathol       Date:  2016-10-24       Impact factor: 2.007

4.  Immaturity associated antigens are lost during induction for T cell lymphoblastic leukemia: implications for minimal residual disease detection.

Authors:  Mikhail Roshal; Jonathan R Fromm; Stuart Winter; Kimberly Dunsmore; Brent L Wood
Journal:  Cytometry B Clin Cytom       Date:  2010-05       Impact factor: 3.058

5.  Immunophenotypic characteristics of T lineage acute lymphoblastic leukemia: absence of immaturity markers-TdT, CD34 and HLADR is not uncommon.

Authors:  Richa Gupta; Neha Garg; Mrinalini Kotru; Dilip Kumar; Rajesh Pathak
Journal:  Am J Blood Res       Date:  2022-02-15

6.  Terminal deoxynucleotidyl transferase negative T-cell lymphoblastic lymphoma in aleukemic patient.

Authors:  Iva Brčić; Boris Labar; Melita Perić-Balja; Sandra Bašić-Kinda; Marin Nola
Journal:  Int J Hematol       Date:  2008-05-31       Impact factor: 2.490

Review 7.  Diagnosis and subclassification of acute lymphoblastic leukemia.

Authors:  Sabina Chiaretti; Gina Zini; Renato Bassan
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-11-01       Impact factor: 2.576

8.  Cutaneous T-Cell Acute Lymphoblastic Leukemia and the Expression Pattern of Terminal Deoxynucleotidyl Transferase Immunostaining in Mycosis Fungoides and Spongiotic Dermatitis.

Authors:  Joshua J Clark; Jason E Hawkes; Scott R Florell; Rodney R Miles; David A Wada
Journal:  Dermatopathology (Basel)       Date:  2019-09-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.